MedTrace Logo

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer

NCT05471427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2022-07-22

No results posted yet for this study

Summary

Aiming to explore predictive factors of fitness to taxane chemotherapy in elderly patients, the investigators collected data from a prospective mono-centric database of patients aged \>/= 70 years old treated in our department, and explored association between baseline age, G8 score and Charlson comorbidity index with taxane dose reduction, treatment temporary suspension or definitive interruption.

Conditions

Interventions

DRUG

Taxane chemotherapy

Patients underwent taxane chemotherapy according to clinical practice for metastatic prostate cancer

Sponsors & Collaborators

  • Azienda Ospedaliero-Universitaria Careggi

    lead OTHER

Principal Investigators

  • Lorenzo LL Livi · Azienda Ospedaliero-Universitaria Careggi

Eligibility

Min Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-07-01
Completion
2022-07-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471427 on ClinicalTrials.gov